References

References:

  1. Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
  2. Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman disease: an overview. J Clin Pathol. 2020; 73: 697-705.
  3. Diamond EL, Durham BH, Haroche J, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov. 2016; 6: 154-165.
  4. Garces S, Medeiros LJ, Patel KP, et al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol. 2017; 30: 1367-1377.
  5. Green I, Dorfman RF, Rosai J. Breast involvement by extranodal Rosai-Dorfman disease: report of seven cases. Am J Surg Pathol. 1997; 21: 664-668.
  6. Bansal P, Chakraborti S, Krishnanand G, et al. Rosai-Dorfman disease of the breast in a male: a case report. Acta Cytol. 2010; 54: 349-352.
  7. Hummel P, Waisman J, Chhieng D, et al. Fine-needle aspiration cytology of Rosai-Dorfman disease of the breast: a case report. Diagn Cytopathol. 1999; 21: 287-291.
  8. Ravindran A, Goyal G, Go RS, et al. Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2. Am J Surg Pathol. 2021; 45: 35-44.
  9. Garces S, Medeiros LJ, Marques-Piubelli ML, et al. Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activation. Hum Pathol. 2022; 121: 36-45.
  10. Cheuk W, Chan AC, Lam WL, et al. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol. 2009; 33: 1058-1064.
  11. Dorokhova O, Fineberg S, Koenigsberg T, et al. Diabetic mastopathy, a clinicopathological correlation of 34 cases. Pathol Int. 2012; 62: 660-664.
  12. Rodrigues C, Santos P, Simoes D, et al. Langerhans cell histiocytosis and breast. Acta Med Port. 2011; 24 Suppl 3: 713-714.
  13. Provenzano E, Barter SJ, Wright PA, et al. Erdheim-chester disease presenting as bilateral clinically malignant breast masses. Am J Surg Pathol. 2010; 34: 584-588.
  14. Natkunam Y, Rossi S, Demicco ES. Rosai-Dorfman disease. In: Board WCoTE, ed. WHO Classification of Tumors Hematolymphoid Tumors. Lyon (France): IARC, 2022.
  15. Thomas A, Link BK, Altekruse S, et al. Primary breast lymphoma in the United States: 1975-2013. J Natl Cancer Inst. 2017; 109.
  16. Shimizu S, Kitamura H, Ito T, et al. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies. Pathol Int. 1998; 48: 549-556.